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Abstract
Background: Essential tremor is a common movement disorder with a strong heritable component. Large families with inherited forms of essential tremor have
undergone genetic analyses by different approaches. However, our knowledge of genetic variants unequivocally linked to essential tremor is remarkably limited.
Several explanations have been put forth to explain this challenge, including the possibility of mutations in non-coding areas of the genome.
Methods: We encountered a family with highly penetrant, autosomal dominant tremor. We hypothesized that, if a single coding gene mutation was responsible for
the phenotype, novel genetic tools would allow us to identify it. We employed single nucleotide polymorphism (SNP) arrays in 17 members of this family followed by
next generation whole-exome sequencing in five affected subjects.
Results: We did not identify any copy number variant or mutation that segregated with the disease phenotype.
Discussion: This study emphasizes the remarkably challenging field of tremor genetics and indicates that future studies should perhaps shift to analysis of the non-
coding genome.
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Introduction
Essential tremor (ET) is one of the most common movement
disorders.1,2 A clinically and etiologically heterogeneous syndrome,
both genetic and environmental causes have been implicated in the
pathogenesis of ET.3–6 The identification of gene variants that cause
ET would facilitate the development of animal models to study the
neurobiology underlying this syndrome and for rational therapeutic
design. However, ET genetics is a surprisingly challenging area of
movement disorders research.6 Despite the high prevalence of ET
families following a Mendelian pattern of inheritance, the number of
causative genes conclusively linked to ET remains negligible. This
contrasts with the multiple genes that are known to be implicated in
the etiology of other movement disorders, such as Parkinson’s disease
(PD), despite a lower prevalence and infrequent monogenic
pedigrees.7
Microsatellite-based linkage studies in single families identified
several loci linked to ET and candidate genes,4,5,7 but were not
successful in the identification of gene variants that unequivocally
segregate with the disease. Recently, we have witnessed remarkable
advances in the availability of tools used to identify disease-causing
genes.8 Two examples are the use of genome-wide single nucleotide
polymorphism (SNP) arrays and next-generation sequencing. These
novel techniques significantly increased efficiency and reduced costs of
human genetic studies. They have been applied to the study of ET. For
instance, a genome-wide association study (GWAS) completed in a
large Icelandic and North American population identified an
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association between a SNP close to the LINGO1 gene and ET.9
However, mutations in LINGO1 do not cause Mendelian forms of ET,
and this SNP is located in a non-coding sequence. Therefore, how this
variant is associated with ET remains unknown. Another GWAS in
patients with ET identified SLC1A2 as a potential susceptibility gene
for ET.10 More recently, whole-exome sequencing identified mutations
in the FUS gene in patients with ET,11 though follow-up studies
suggest that this is a very rare cause of ET. An important step in this
direction would be to identify genetic variants that cause ET in families
that follow an autosomal dominant pattern of inheritance.
In this study, we identified a family with autosomal dominant ET
and hypothesized that combining the use of SNP arrays and next
generation sequencing would allow us to identify causative genetic
variants that segregate with the ET phenotype.
Methods
Subjects
Through the evaluation of an index case in our Movement
Disorders Clinic, we identified a family with multiple members
affected by ET. All family members were invited to participate in the
study. After obtaining informed consent, participants underwent an
interview and neurological examination by a neurologist with expertise
on movement disorders, recording pertinent information on the
presence of tremor, other medical problems, and treatments received.
Specific maneuvers used to elicit the tremor included arm extension,
pouring water, drinking water, finger to nose, and drawing a spiral.
The Washington Heights–Inwood Genetic Study of Essential Tremor
criteria for probable or definite ET were used. Information on the
presence of tremor in family members not examined, and therefore not
included in the genetic study, was obtained from participants to
determine type of inheritance. To generate a pedigree, non-examined
relatives were considered as affected if at least two other family
members reported the unequivocal presence of tremor. This study was
reviewed and approved by the University of Iowa Institutional Review
Board.
Genetic studies
Blood samples were obtained from participating subjects and
genomic DNA was isolated following standard procedures. Genome-
wide genotyping was performed using Affymetrix GeneChip Human
Mapping 250K Array in the DNA Core Facility at the University of
Iowa following the manufacturer’s protocols (Affymetrix, Santa Clara,
CA). Genotypes were called using GeneChip DNA Analysis Software
(GDAS version 3).
For linkage, nonparametric and parametric analyses were per-
formed using ALLEGRO (version 2.0) through the graphical user
interface EasyLinkage Plus. Non-informative SNPs were removed
from analysis. The marker spacing was set to 0.8 cM, and we assumed
equal marker allele frequencies. For the parametric analyses, we
specified an autosomal dominant model with 0.005 disease allele
frequency, 0.99 penetrance for both heterozygous and homozygous
disease allele carriers, and 0.01 phenocopy rate. Simulations (1,000
replicates) were also performed using Simwalk (version 2.91) and the
same genetic parameters. The .CEL files from the Affymetrix arrays
were analyzed for copy number using the default parameters within
the Hidden Markov Model (HMM) within the Partek Genomics Suite
(Partek Inc, St. Louis, MO). Copy Number Variants were annotated
for gene content and overlap with CNVs in the Database of Genomic
Variants (http://dgv.tcag.ca/dgv/app/home). Using an autosomal
dominant model, we tested for CNVs that were common to all the
affected individuals but not detected in unaffected family members.
For next-generation sequencing, the Agilent SureSelect Version 4
(51 Mb) exome enrichment kit was used prior to sequencing on an
Illumina HiSeq 2000 instrument. One hundred nucleotide-long paired
end reads were used to sequence each exome to an average coverage of
approximately 506 before the removal of PCR duplicates. We
followed the best practice variant detection guidelines for sequence
analysis developed by the Broad Institute for the Genome Analysis
Tool Kit (GATK) suite of software utilities.12 The overall process,
which we have previously described in more detail,13 consists of three
stages—alignment to the reference genome, identification of high-
quality variations and genotypes, and annotation with biologically
relevant information. We identified variants that were found at greater
than 1% in the 1000 Genomes Project, dbSNP, and the Exome
Variant Server. All variants were also compared to our own internal
database of exome-sequencing results from patients without the same
phenotype. Following these initial variant filtration steps, annotation of
remaining variants was performed using SnpEff and SnpSift,14 the
dbNSFP,15 and the Human Gene Mutation Database Professional
Version (HGMD).16 Variation prioritization was accomplished by
three methods: 1) heuristic filtering based on suspected disease
inheritance, 2) likely variant functional consequence, and 3) a
probabilistic search algorithm, VAAST.17 Various quality control
metrics were used throughout the analysis process. Fastq files were
evaluated using FastQC, mapping was evaluated using both Samtools
and Qualimap and variant quality was assessed using parallel strategies
of hard filtering and variant quality score recalibration. We assumed
that any causative variant would be transmitted in a dominant manner
and exhibit complete penetrance. VarSifter18 was used to perform the
inheritance based, variant segregation analysis.
Results
A total of 17 subjects participated in this study, undergoing an
interview and examination followed by genetic analysis. Nine were
determined to be affected by tremor, a woman assigned to be an obligate
carrier (subject IV.15, who had a son with the typical head and hand
tremor as described by all subjects) and three subjects were non-affected.
Four subjects were excluded from the genetic analysis because the
presence of ET was equivocal. One had late onset PD with a component
of action tremor (subject III.14). Two reported occasional mild head
tremor, but this was not observed by examination or noted by other
family members (subjects IV.13 and IV.23). Another subject described
the rare presence of mild action tremor in both upper extremities that
was not detected by exam (subject IV.30). All participants provided
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information on the presence of tremor on non-participating family
members. There was agreement in all but two subjects (subjects IV.7
and V.6). This information was used to generate a pedigree that
indicated autosomal dominant inheritance shown by the presence of
male to male transmission (Figure 1).
All affected subjects but one met criteria for definite or probable ET
according to the Washington Heights–Inwood Genetic Study of
Essential Tremor criteria,19 and in more than half the head was
prominently involved. The subject who did not meet criteria did not
exhibit arm tremor, but isolated head tremor. We are confident that
this phenotype represents the same tremor as other subjects, as the
head tremor was significant and phenotypically comparable to other
affected subjects. Another had very mild cervical dystonia without
head tremor but with upper extremity action tremor (Table 1).
However, the head tremor present in other subjects had the
characteristics of head tremor of ET and not dystonic tremor.
The Affymetrix GeneChip array data were analyzed for CNVs. We
compared CNVs detected in affected versus unaffected individuals. We
Figure 1. The Pedigree of the Reported Family Is Consistent with an Autosomal Dominant Inheritance Pattern. The proband is indicated with an
arrow. Deceased individuals are crossed by a slash. Note that many subjects of the V generation are not included in the pedigree as most were in the first two decades of
life. Only the reportedly affected subjects from that generation and their siblings are shown.
Table 1. Clinical Characteristics of Tremor in Included Subjects
Subject Current Age Age Onset1 Location Severity (arm)2
III.7 80 16 Arms/head/voice 3
III.9 78 50 Arms/head/voice 3
III.11 70 40 Arms/head/voice 3
IV.8 51 35 Arms3 2
IV.12 56 20 Arms/head 2
IV.17 42 38 Head 0 (only head)
IV.21 48 45 Arms 2
IV.27 48 20 Arms 2
IV.28 42 14 Arms 3
Mean (¡SD) 57.2 (¡14.9) 30.9 (¡13.5)
1Approximate age reported by the subjects.
2Washington Heights–Inwood Genetic Study of Essential Tremor Severity Score.
3Mild cervical dystonia.
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did not detect any CNVs that segregated with the disease phenotype.
We detected an average of 34 CNVs per individual and did not detect
any variation in CNV burden between affected and unaffected
individuals. There were three CNVs within 2p11.2, 8p11.23-p11.22
and 14q32.33, respectively that were detected in all affected subjects.
But, upon further analysis they were also detected in some or all of the
tested, unaffected family members and were later confirmed as
common CNVs in the general population.
Next, we used the SNP data to complete a linkage analysis. We
identified a two-point logarithm of odds score .2 in chromosome 4
(Figure 2), although this did not reach the LOD.3 required for evidence
of linkage. To identify any potential mutations in this or other genomic
loci, we then pursued next-generation, whole-exome sequencing in five
affected subjects (III.7, III.9, III.11, IV.12, and IV.17). Surprisingly, this
analysis also did not find any mutations shared by the five subjects. We
specifically looked for variants in known ET genes. There were no rare
(,1% Minor allele frequency), coding mutations within any of the five
affected members in the genes LINGO1, SLC1A2, or FUS.
Discussion
In this study, we employed novel genetic technologies to study a
family with autosomal dominant ET. However, we did not identify
any CNV or mutation segregating with the disease. These results are
consistent with previous studies that highlight the challenge of ET
genetics. The absence of a shared mutation in the exonic sequence of
five affected subjects indicates that either non-coding genes play an
important role in the etiology of monogenic ET, or that ET follows a
more complex inheritance pattern as previously suggested by
others.20
The family described here has clinical features similar to other
previously reported pedigrees, although with some interesting
characteristics. It includes many subjects with typical ET affecting
the upper extremities, but also several subjects with more prominent
head tremor and a woman with comorbid mild cervical dystonia. The
presence of prominent head tremor in many subjects and at a relatively
young age is not very common. It is possible that this is a result of the
interesting relationship between ET and dystonia. While these subjects
exhibited the typical characteristics of ET-related head tremor, and
not a dystonic head tremor, the potential contribution of a dystonic
disorder cannot be entirely ruled out. Lou and Jankovic21 reported the
presence of dystonia in a large proportion of patients with ET and the
same group studied described families with inherited ET co-existing
with dystonia.22 More recently, Hedera and colleagues23 reported 97
kindreds with autosomal dominant ET, and found that 28% of those
pedigrees included subjects with dystonia. Consistent with previous
studies illustrating the clinical heterogeneity of ET, these and other
reports indicate that families with autosomal dominant ET that include
subjects with dystonia represent a subtype of ET. Our family would
belong to this subgroup of ET. Clustering large families into similar
phenotypes, such as the ET-dystonia subtype, will likely aid in future
genetic studies to reduce the noise caused by etiological heterogeneity.
It is possible that sequence variants in non-coding genes could
underlie at least some forms of inherited ET. This would explain the
difficulty in identifying causative genes in families with an apparent
Figure 2. Linkage Analysis. Illustration of the Only Genomic Region with a LOD Score .2 in the Linkage Analysis.
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Mendelian mode of inheritance when focusing on the analysis of
protein-coding genes. The role of non-coding RNAs in the pathogenesis
of neurological diseases is just beginning to unfold.24,25 In the future,
sequencing studies in families with ET should include protocols to isolate
and sequence small RNAs. For instance, RNA-Seq of small RNAs
extracted from blood samples or brains obtained from ET patients could
serve to both sequence and quantify expression levels of hundreds of
neurally expressed microRNAs. Furthermore, whole-genome, rather
than whole-exome, sequencing could help identify mutations in non-
coding regions. However, the increased cost and lower degree of
sequence conservation in non-expressed regions will add some difficulty
to this task. Other potential causes for the repeated lack of success in
genetic studies in ET include complex modes of inheritance or the
presence of phenocopies in this frequent syndrome. In fact, a
fundamental problem with ET genetics resides in the definition of the
phenotype and its highly variable penetration and expressivity. In the
context of rare coding variants, it is plausible that we are not facing
single highly penetrant coding variants that segregate with the
phenotype, but a collection of rare variants with variable penetrance
that result in a heterogeneous phenotype. Finally, the existing
publication bias against ‘‘negative’’ studies might represent another
obstacle, as studies of families with common phenotypical and genetic
features performed by different groups probably remain unknown,
preventing the design of collaborative studies with larger sample sizes.
In summary, the identification of genetic variants that cause ET in
families with an apparent autosomal dominant mode of inheritance
remains a challenge. Large collaborative studies, including multiple
families with similar phenotypic subtypes and employing novel sequen-
cing techniques that evaluate coding and non-coding sequences, should
be pursued in the quest to identify genetic mutations that cause ET. In
parallel, establishing collaborations to group and analyze linkage and
sequencing data already obtained by different groups in different families,
such as ours, could yield interesting data with no added costs. Either way,
the field would benefit from the organization of an international network
of investigators focused on the study of ET genetics.
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